The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.
Deborah R. Kaye, MD, MS
Advertisement
Articles by Deborah R. Kaye, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
2
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
3
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
4
CKD Stage, Proteinuria Tied to Higher HCRU in IgAN
5